ProShare Advisors’s Applied Genetic Technologies Corporation AGTC Stock Holding History

ProShare Advisors’s Portfolio AGTC Stock Details AGTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-11,430	Closed	-$58K	–	2429
2021 Q1	$58K	Buy	+11,430	New	+$59.3K	﹤0.01%	2216
2016 Q4	–	Sell	-12,630	Closed	-$124K	–	1759
2016 Q3	$124K	Sell	12,630 -2,350	-16%	-$31.7K	﹤0.01%	1400
2016 Q2	$212K	Buy	14,980 +547	+4%	+$8.53K	﹤0.01%	1388
2016 Q1	$202K	Sell	14,433 -1,325	-8%	-$19.4K	﹤0.01%	1414
2015 Q4	$321K	Buy	+15,758	New	+$243K	﹤0.01%	1254

Other funds holding AGTC

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

IVM

InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return

PCM

Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

ProShare Advisors's AGTC Position: Q2 2021 in Review

ProShare Advisors sold out of Applied Genetic Technologies Corporation (AGTC) in Q2 2021, closing a stake of 11,430 shares — an estimated $58K sold.

ProShare Advisors first reported a position in AGTC in Q4 2015 and held it in 5 quarters. The position peaked at $321K in Q4 2015. 71 funds tracked by Wall St. Rank hold AGTC as of Q2 2021.

ProShare Advisors reported no remaining Applied Genetic Technologies Corporation position as of Q2 2021 after selling out during the quarter.
ProShare Advisors sold 11,430 Applied Genetic Technologies Corporation shares in Q2 2021, an estimated $58K.
ProShare Advisors first reported a position in Applied Genetic Technologies Corporation in Q4 2015 and held it in 5 quarters.
ProShare Advisors's Applied Genetic Technologies Corporation position peaked at $321K in Q4 2015.
71 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q2 2021.

Based on ProShare Advisors's 13F filing for Q2 2021, filed 13 Aug 2021.